
|Videos|March 24, 2022
Advice to physicians on implementing immunotherapy in their practice
Author(s)Urology Times staff
Advertisement
In this video, Susan F. Slovin, MD, PhD, discusses considerations that physicians should know when they are beginning to implement immunotherapy in their practice, which are ideas associated with a presentation that she gave at the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies. Slovin is a medical oncologist at the Memorial Sloan Kettering Cancer Center in New York City, New York.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












